All the news Showing 8 of 18 articles from: EASL 2019Get an RSS feed of these articles Show All news infohep newsEditors' picks from other sources NAFLD Experts warn of fatty liver disease 'epidemic' in young people The Guardian / 12 April 2019 Access to medicines & diagnostics Global hepatitis response gains ground – More action needed to achieve universal health coverage targets World Health Organization / 12 April 2019 NAFLD Second-generation thiazolidinedione, MSDC-0602K may significantly improve liver enzymes, fibrosis, and glycaemic markers with minimal adverse events, according to a Phase 2b study EASL / 12 April 2019 Treatment for previous non-responders & relapsers ‘Real-world’ studies in Germany and the USA confirm high rates of sustained virological response with sofosbuvir/velpatasvir/voxilaprevir (SOF/VEL/VOX) in individuals with chronic HCV infection failing DAAs EASL / 12 April 2019 Finance, funding & health economics $51 billion price tag for eliminating hepatitis C by 2030 Keith Alcorn / 11 April 2019 To achieve hepatitis C elimination worldwide by 2030, governments, donors and the private sector will need to spend $51 billion but eliminating hepatitis C will lead to a $19 billion ... Screening policy 30 million screened for hepatitis C in four months in Egypt Keith Alcorn / 11 April 2019 Egypt screened almost 30 million people for hepatitis C in the first four months of a national screening programme that kicked off in October 2018, Egyptian researchers announced at The International Liver Congress ... Screening policy Same-day hepatitis C treatment initiation can be achieved at large scale, Egyptian pilot study shows Keith Alcorn / 11 April 2019 Screening for hepatitis C, confirmation of chronic infection by point-of-care viral load testing and treatment initiation can all be achieved on the same day in a community setting, Egyptian researchers reported at The ... Hepatitis B Global drive for hepatitis B cure launched at International Liver Congress Keith Alcorn / 10 April 2019 The Global Scientific Strategy to Cure Hepatitis B (The ICE-HBV Strategy) by the International Coalition to Eliminate HBV (ICE-HBV), a global group of researchers, patient representatives and health organisations, was released on the opening ... ← Prev12Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive